RMD: Analysis & Opinions

  1. Zimmer Stays at Neutral - Analyst Blog

    February 15, 2013
    We recently reiterated our Neutral recommendation on Zimmer Holdings (ZMH), a leading orthopedic medical devices ...
  2. Thermo Fisher Remains at Neutral - Analyst Blog

    February 13, 2013
    We recently reiterated our Neutral recommendation on Thermo Fisher Scientific (TMO), a major scientific instrument ...
  3. Merge Extends Customer Base - Analyst Blog

    February 13, 2013
    Imaging and interoperability solutions provider Merge Healthcare Incorporated (MRGE) has extended its customer base ...
  4. Stryker Hits 52-Week High - Analyst Blog

    February 13, 2013
    Shares of Stryker Corp. (SYK) hit a new 52-week high of $64.10, before closing on Tuesday, Feb 12 at $63.01. The ...
  5. CE Mark for BSX's Promus Premier - Analyst Blog

    February 13, 2013
    Boston Scientific (BSX) has expanded its drug eluting stent ("DES") portfolio with the CE Mark approval for the ...
  6. STJ Presents RESPECT Trial Data - Analyst Blog

    February 12, 2013
    Medical devices major, St. Jude Medical Inc. (STJ), presented additional data from the RESPECT clinical trail at the ...
  7. Still Neutral on Cepheid - Analyst Blog

    February 12, 2013
    On Feb 5, 2013, we reaffirmed our Neutral recommendation on Cepheid Inc (CPHD) following the fourth quarter 2012 ...
  8. Epocal Acquired by Alere - Analyst Blog

    February 12, 2013
    Alere (ALR), a medical products company focused on integrating rapid diagnostics with health management, recently ...
  9. Life's Products Gain FDA Approval - Analyst Blog

    February 12, 2013
    Global biotechnology tools company - Life Technologies Corporation (LIFE) recently received 510(k) clearance from ...
  10. Smith & Nephew Beats in 4Q - Analyst Blog

    February 12, 2013
    Smith & Nephew plc (SNN) reported earnings per share (EPS) of 15.8 cents or EPADS of 79 cents in the fourth quarter ...
  11. Solid 4Q for Conceptus - Analyst Blog

    February 11, 2013
    Contraception device maker- Conceptus Inc. (CPTS) reported earnings per share (EPS) of 17 cents during the fourth ...
  12. Covidien Issues STAR Trial Data - Analyst Blog

    February 08, 2013
    International health care products major, Covidien plc. (COV) announced results of the two-year "Solitaire FR ...
  13. Another Challenging Quarter for LH - Analyst Blog

    February 08, 2013
    Laboratory Corporation of America Holdings (LH) reported net earnings of $120.2 million or $1.26 per share in the ...
  14. Myriad Tops Estimates; Tweaks View - Analyst Blog

    February 08, 2013
    Myriad Genetics Inc. (MYGN) reported EPS of 42 cents in the second quarter of fiscal 2013, representing a beat of ...
  15. A Mixed Quarter for Hologic - Analyst Blog

    February 08, 2013
    Hologic (HOLX) reported net income of $3.1 million or a penny per share in the first quarter of fiscal 2013 compared ...
  16. Genomic Beats Estimates - Analyst Blog

    February 08, 2013
    Genomic Health (GHDX) reported fourth-quarter 2012 net income of $2.0 million, down from $2.6 million in the ...
  17. All-Front Beat for CVS, Up Y-Y - Analyst Blog

    February 06, 2013
    CVS Caremark (CVS) reported fourth-quarter 2012 EPS of 90 cents, up 11.1% year over year. However, excluding the ...
  18. MWI Vet Beats with Ease in 1Q13 - Analyst Blog

    February 06, 2013
    MWI Veterinary Supply Inc. (MWIV) reported first-quarter fiscal 2013 EPS of $1.32, up 25.7% on a year-over-year ...
  19. DGX Downgraded to Underperform - Analyst Blog

    February 05, 2013
    On Feb 1, we downgraded Quest Diagnostics (DGX), a leading player in the diagnostic testing market, to Underperform ...
  20. Becton Beats Again, Guides High - Analyst Blog

    February 05, 2013
    Medical technology major Becton, Dickinson and Company (BDX) reported first-quarter fiscal 2013 earnings per share ...
Marketplace
Trading Center